![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, August 10, 2004 5:45:10 AM
http://www.eternalhealth.org/doctor/michael_elstein.htm
http://www.eternalhealth.org/archives/whats_new/june%201sta%202004.htm
Sarcoidosis, emphysema, SARS, West Nile virus and aging update
Two weeks ago one of the questions concerned treatment for sarcoidosis and I indicated that treatment of a bacterium thought to underly this disease might lead to significant improvements. What I have since discovered via communication with an extremely brilliant physician and research scientist Dr David Moskowitz whose website is located at www.genomedics.com is that angiotensin 2, a substance manufactured in the lung might be responsible for the promotion of sarcoidosis, emphysema, SARS and even ageing. Now angiotensin 2 is the chemical that is also responsible for raising blood pressure and we have medications commonly known as ACE inhibitors and angiotensin receptor blockers or ARBs for modulating angiotensin 2 which reduces blood pressure. According to ground-breaking research conducted by Dr Moskowitz and his colleagues angiotensin 2 might also instigate the promulgation of free radicals and at the same time might be responsible for the processes that drive sarcoidosis, emphysema, SARS, West Nile Virus disease and even aging. In other words medications that are commonly reserved for the treatment of high blood pressure can also be used to treat sarcoidosis, emphysema, viral illnesses such as SARS and even to prevent aging. I suggest you look at the above website to get acquainted with this exciting new research.
Recent GMED News
- Globus Medical Launches ADIRA™ XLIF™ Plate System • GlobeNewswire Inc. • 08/21/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 09:10:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:20:25 PM
- Globus Medical Reports Second Quarter 2024 Results • GlobeNewswire Inc. • 08/06/2024 08:15:00 PM
- Globus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System • GlobeNewswire Inc. • 07/17/2024 12:30:00 PM
- Globus Medical Schedules Second Quarter Earnings Release and Conference Call • GlobeNewswire Inc. • 07/16/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 08:25:27 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/11/2024 03:07:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 08:15:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 09:16:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 08:48:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/10/2024 08:15:52 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/10/2024 04:11:54 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/08/2024 08:11:33 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/08/2024 07:59:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:21:08 PM
- Globus Medical Reports First Quarter 2024 Results • GlobeNewswire Inc. • 05/07/2024 08:15:00 PM
- Globus Medical Schedules First Quarter Earnings Release and Conference Call • GlobeNewswire Inc. • 04/16/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:07:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 11:50:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 09:35:42 PM
- Globus Medical Reports Fourth Quarter and Full Year 2023 Results • GlobeNewswire Inc. • 02/20/2024 09:15:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:08:54 PM
- Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call • GlobeNewswire Inc. • 02/13/2024 10:17:08 PM
FEATURED Mawson Finland Provides Update on Exploration Activities at Rajapalot • Aug 21, 2024 9:06 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM
Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions • AVAI • Aug 21, 2024 8:00 AM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM